Evidence for Trisulfide Bonds in a Recombinant Variant of a Human IgG2 Monoclonal Antibody

被引:60
作者
Pristatsky, Pavlo [1 ]
Cohen, Steven L. [1 ]
Krantz, Debra [1 ]
Acevedo, Jillian [1 ]
Ionescu, Roxana [1 ]
Vlasak, Josef [1 ]
机构
[1] Merck Res Labs, West Point, PA 19486 USA
关键词
MASS-SPECTROMETRY; SUPEROXIDE-DISMUTASE; PURIFICATION; HETEROGENEITY; PATHWAYS; PROTEIN; HINGE; LINK;
D O I
10.1021/ac9006254
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The hinge region of human IgG2 contains four cysteine residues involved in disulfide linkages between the heavy chains, as well as the heavy and light chains. These linkages provide the fundamental framework of three distinct IgG2 disulfide isoforms recently described. Here, we detail another, disulfide-related post-translational modification in a recombinant variant of human IgG2. Heterogeneity associated with this antibody was separated into several fractions by anion-exchange chromatography (AEX), which is an important initial step that highlights the resolving power of surface charge-based HPLC techniques. Mass spectrometry of the intact antibody revealed weakly resolved discrete covalent additions of 25-35 Da in one of the two main AEX fractions. Digestion by endoproteinase Lys-C performed under nonreducing conditions, as well as tandem MS experiments, narrowed the modification to the peptide-containing disulfide-bridged hinge structure. High mass resolution and accuracy measurements of the peptide strongly suggested an addition of one or two S atoms. The modification could be eliminated by a mild reducing treatment of the intact antibody. Overall, these findings are consistent with the replacement of up to two disulfide bridges (S-S) with a like number of trisulfides (S-S-S) in the antibody hinge. The trisulfide modification is rather uncommon for proteins and its possible origins in the IgG2 variant are discussed.
引用
收藏
页码:6148 / 6155
页数:8
相关论文
共 44 条
[1]   Scale-up of monoclonal antibody purification processes [J].
Aldington, Suzanne ;
Bonnerjea, Julian .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 848 (01) :64-78
[2]  
Andersson C, 1996, INT J PEPT PROT RES, V47, P311
[3]   Removal of cysteinylation from an unpaired sulfhydryl in the variable region of a recombinant monoclonal IgG1 antibody improves homogeneity, stability, and biological activity [J].
Banks, Douglas D. ;
Gadgil, Himanshu S. ;
Pipes, Gary D. ;
Bondarenko, Pavel V. ;
Hobbs, Vipa ;
Scavezze, Joanna L. ;
Kim, Jun ;
Jiang, Xu-Rong ;
Mukku, Venkat ;
Dillon, Thomas M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (02) :775-790
[4]   Antibodies for the treatment of bacterial infections: current experience and future prospects [J].
Bebbington, Christopher ;
Yarranton, Geoffrey .
CURRENT OPINION IN BIOTECHNOLOGY, 2008, 19 (06) :613-619
[5]  
Becker P, 2006, Patent, Patent No. [WO 2006/069940, 2006069940]
[6]   Antibody production [J].
Birch, John R. ;
Racher, Andrew J. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (5-6) :671-685
[7]   Therapeutic antibodies for human diseases at the dawn of the twenty-first century [J].
Brekke, OH ;
Sandlie, I .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) :52-62
[8]   THE STRUCTURAL REQUIREMENTS FOR COMPLEMENT ACTIVATION BY IGG - DOES IT HINGE ON THE HINGE [J].
BREKKE, OH ;
MICHAELSEN, TE ;
SANDLIE, I .
IMMUNOLOGY TODAY, 1995, 16 (02) :85-90
[9]   DETECTION OF TRACES OF A TRISULFIDE DERIVATIVE IN THE PREPARATION OF A RECOMBINANT TRUNCATED INTERLEUKIN-6 MUTEIN [J].
BRETON, J ;
AVANZI, N ;
VALSASINA, B ;
SGARELLA, L ;
LAFIURA, A ;
BREME, U ;
ORSINI, G ;
WENISCH, E ;
RIGHETTI, PG .
JOURNAL OF CHROMATOGRAPHY A, 1995, 709 (01) :135-146
[10]  
BRIGGS RG, 1978, BIOCHIM BIOPHYS ACTA, V537, P100, DOI 10.1016/0005-2795(78)90606-2